PHOTOCURE
PHOTOCURE
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1997-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.photocure.com
Total Employee:
51+
Status:
Active
Contact:
(609)759-6500
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Nginx Euro Microsoft Exchange Online Amazon Office 365 Mail
Current Advisors List
Current Employees Featured
Stock Details
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-01 | Photocure appoints Anders Neijber as Vice President, Global Medical Affairs and Clinical Development |
Official Site Inspections
http://www.photocure.com Semrush global rank: 5.66 M Semrush visits lastest month: 1.49 K
- Host name: 137.221.25.148
- IP address: 137.221.25.148
- Location: Oslo Norway
- Latitude: 59.9061
- Longitude: 10.7392
- Timezone: Europe/Oslo
- Postal: 0191
More informations about "Photocure"
Photocure, The Bladder Cancer Company
Photocure, The Bladder Cancer Company Bladder cancer is a global challenge. By focusing on improving bladder cancer management, we are delivering transformative solutions that make a …See details»
Photocure - Crunchbase Company Profile & Funding
Photocure, the world leader in photodynamic technology, is a Norwegian based specialty pharmaceutical company.See details»
Photocure, The Bladder Cancer Company
Investor information Photocure shareholders enjoy the benefits of our strong, global company vision, expertise and transparent approach to business.See details»
Photocure - Wikipedia
Photocure ASA is a Norwegian specialty pharma company that develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology. Photocure's strategy in cancer is to continue the commercialization of Hexvix for bladder cancer diagnostics, and continue the development of the cancer portfolio and out-license prior to phase III studies. This strategy is based on a strong platform of intellectual property in photodynamic therapy. See details»
Photocure - LinkedIn
About Photocure Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow …See details»
Your press and media enquiry hub - Photocure
Photocure summaries: Key information about our company and products If you are new to the Photocure story and business, you can find information about the company history here and …See details»
2022 Annual R - cms.photocure.com
Photocure is committed to Good Corporate Governance ers. The Company’s framework for corporate governance is intended to decrease business risk, maximize value and utilize the …See details»
2020 - Photocure
Encompasses all activities from developing products, gaining approval by relevant authorities, working with patient organizations and hospitals, and finally getting products to the market …See details»
Photocure Company Profile - Office Locations, Competitors, …
Oct 11, 2024 Photocure, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products and …See details»
PHOTOCURE ASA RESULTS FOR 2ND QUARTER 2020
The Presentation has been produced by Photocure (the “Company”) for information purposes only and does not in itself constitute, and should not be construed as, an offer to sell or a …See details»
Photocure Canada Inc. Company Profile | Toronto, ON, Canada ...
Find company research, competitor information, contact details & financial data for Photocure Canada Inc. of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»
Investor events and presentations - Photocure
Aug 14, 2020 Congresses Photocure will be present at key international and regional Urology Congresses, Investor Conferences and Industry Events.See details»
Photocure ASA: Notification of primary insider transaction - Cision …
5 days ago About Photocure ASAPhotocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique …See details»
Photocure Board Member Acquires Shares, Boosting Confidence
5 days ago Board member Ghizlane Tagmouti of Photocure ASA has recently acquired 20,218 shares at an average price of NOK 50.186, signaling potential confidence in the company’s …See details»
About Photocure - Hexvix
Home News Hexvix ® Hexvix ® Patient Journey Hexvix ® Resource Center Contact us About Photocure References Safety InformationSee details»
Corporate Social Responsibility Our Mission and Vision Our
Our Mission and Vision Our Vision: Leading change in bladder cancer. Everyone at Photocure has a shared focus, and that's to make a continuous, positive impact on the lives of our …See details»
News - Photocure
Nov 12, 2024 The latest news and updates from Photocure and the bladder cancer therapy areaSee details»
First Quarter Results 2023 - Photocure
Commercial segment update Photocure’s first quarter 2023 results benefited from a recovery in unit sales volume from the fourth quarter of 2022 in both the North American and European …See details»
Photocure : to Sell BioSyent Pharma's Cysview Drug in Canada
-- Photocure on Wednesday entered an agreement with BioSyent Pharma to reacquire marketing and distribution rights for Cysview, a bladder cancer treatment product, in Canada. Under the …See details»
Photocure technology
May 23, 2024 Photocure Technology® Uniquely selective, minimally invasive. Combining drug and light for treatment and diagnosis Our unique photodynamic technology combines the …See details»